 salmeterol nocturn asthma doubl blind placebo trial long act agonist object inhal salmeterol new long act beta adrenerg agonist nocturn bronchoconstrict sleep qualiti patient nocturn asthma design doubl blind placebo crossov studi set hospit outpati clinic edinburgh subject twenti stabl patient women men nocturn asthma median age year intervent salmeterol microgram microgram placebo morn even dose inhal rescu salbutamol inhal run period main outcom measur improv nocturn asthma peak expiratori flow rate chang sleep qualiti electroencephalographi result salmeterol overnight peak flow rate microgram differ median valu confid interv differ median l/min microgram l/min twice salmeterol microgram daili patient object improv sleep qualiti time awak light sleep min time stage sleep min conclus salmeterol effect long inhal bronchodil patient nocturn asthma dose microgram daili improv object sleep qualiti